CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 6
- ScaleMarket cap is $1.92B, above the global median of $1.15B
- FinancialsAltman Z-Score 0.95: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.92BCNY1.92B · vs all stocks (USD)
Revenue (TTM)
11.05BCNY1.64B · vs all stocks (USD)
Profit Margin
-3.52%vs Chemicals peers
Beta
0.8000xvs all stocks
52-Week Change
29.42%vs all stocks
Market Capitalization
12.92BCNY1.92B · vs all stocks (USD)
Enterprise Value
19.25BCNY2.86B · vs all stocks (USD)
Forward P/E
16.10xvs Chemicals peers
Price to Sales (TTM)
1.17xvs Chemicals peers
Price to Book (MRQ)
2.46xvs Chemicals peers
Enterprise to Revenue
1.74xvs Chemicals peers
Enterprise to EBITDA
32.29xvs Chemicals peers
Gross Margin
13.59%vs Chemicals peers
Profit Margin
-3.52%vs Chemicals peers
Operating Margin
9.97%vs Chemicals peers
Return on Assets (TTM)
-0.17%vs Chemicals peers
Return on Equity (TTM)
-8.98%vs Chemicals peers
Revenue (TTM)
11.05BCNY1.64B · vs all stocks (USD)
Revenue per Share (TTM)
39.69CNYUpdated Aug 20, 2026Quarterly Revenue Growth
116.40%vs Chemicals peers
Gross Profit (TTM)
516.71MCNY76.74M · vs all stocks (USD)
EBITDA (TTM)
218.93MCNY32.52M · vs all stocks (USD)
Net Income (TTM)
-388.89MCNY-57.76M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
300.58%vs Chemicals peers
Operating Cash Flow (TTM)
-652.06MCNY-96.84M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.19BCNY-176.42M · vs all stocks (USD)
Payout Ratio
0.00%vs Chemicals peers
Minority Interest (Equity)
1.07BCNYFY2025 · Dec 31, 2025Revenue
8.72BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
8.60BCNYFY2025 · Dec 31, 2025Gross Profit
113.40MCNYFY2025 · Dec 31, 2025Operating Income
-393.41MCNY-58.43M · vs all stocks (USD)
Pre-tax Income
-1.16BCNYFY2025 · Dec 31, 2025Income Tax Expense
-75.47MCNYFY2025 · Dec 31, 2025Net Income
-1.09BCNYFY2025 · Dec 31, 2025EBIT
-968.19MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
218.93MCNYFY2025 · Dec 31, 2025Research & Development
176.52MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
66.48MCNYFY2025 · Dec 31, 2025Other Operating Expenses
70.69MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
193.85MCNYFY2025 · Dec 31, 2025EPS (Basic)
-2.95CNYFY2025 · Dec 31, 2025EPS (Diluted)
-2.95CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
278.29MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
278.29MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.09BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
265.63MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-2.16BCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.70BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
725.29MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.09BCNYFY2025 · Dec 31, 2025Other Non-cash Items
303.27MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-855.19MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-523.81MCNYFY2025 · Dec 31, 2025Capital Expenditures
-539.83MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.37BCNYFY2025 · Dec 31, 2025Sale of Investments
4.49BCNYFY2025 · Dec 31, 2025Other Investing Activity
15.60MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-407.36MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
3.22BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.32BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-129.03MCNYFY2025 · Dec 31, 2025Other Financing Charges
171.50MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-52.86MCNYFY2025 · Dec 31, 2025Shares Outstanding
280.19MSharesUpdated Aug 20, 2026Float Shares
206.26MSharesUpdated Aug 20, 2026% Held by Insiders
29.47%vs all stocks
% Held by Institutions
1.96%vs all stocks
Total Cash (MRQ)
2.08BCNY308.28M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.44CNYUpdated Aug 20, 2026Total Debt (MRQ)
7.35BCNY1.09B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.16xvs Chemicals peers
Current Ratio (MRQ)
0.9800xvs Chemicals peers
Book Value per Share (MRQ)
18.71CNYUpdated Aug 20, 2026Total Assets
16.82BCNY2.50B · vs all stocks (USD)
Total Current Assets
6.29BCNYFY2025 · Dec 31, 2025Total Liabilities
10.75BCNYFY2025 · Dec 31, 2025Total Non-current Assets
10.52BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.70BCNYFY2025 · Dec 31, 2025Total Current Liabilities
7.05BCNYFY2025 · Dec 31, 2025Cash
738.66MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.18BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.92BCNYFY2025 · Dec 31, 2025Other Short-term Investments
80.14MCNYFY2025 · Dec 31, 2025Accounts Receivable
2.30BCNYFY2025 · Dec 31, 2025Inventory
1.25BCNYFY2025 · Dec 31, 2025Accounts Payable
3.69BCNYFY2025 · Dec 31, 2025Short-term Debt
3.12BCNYFY2025 · Dec 31, 2025Other Current Liabilities
7.69MCNYFY2025 · Dec 31, 2025Long-term Debt
2.69BCNYFY2025 · Dec 31, 2025Common Stock (Book)
280.19MCNYFY2025 · Dec 31, 2025Retained Earnings
-531.01MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.07BCNY900.84M · vs all stocks (USD)
Treasury Stock
44.17MCNYFY2025 · Dec 31, 202552-Week Low
34.55CNYUpdated Aug 20, 202652-Week High
88.30CNYUpdated Aug 20, 202652-Week Change
29.42%vs all stocks
Beta
0.8000xvs all stocks
50-Day MA
54.19CNYUpdated Aug 20, 2026200-Day MA
51.24CNYUpdated Aug 20, 2026Avg 10-Day Volume
13.36MSharesUpdated Aug 20, 2026Avg 30-Day Volume
15.22MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-1.40CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.95: distress zoneCritical
Altman Z-Score: 0.95
Low earnings qualitySignificant
Earnings Quality Score: -0.51
Supply Chain
Downstream position: depends on 12 industries, supplies 6Notable
Outgoing: 6.00Incoming: 12.00
High connectivity hub: 18 industry connectionsNotable
Total Connections: 18.00
Scale
Market cap is $1.92B, above the global median of $1.15BNotable
Market cap (USD): 1,918,383,475.219Global Median: 1,146,734,693.424
Revenue is $1.64B, above the global median of $520.53MNotable
Revenue (USD): 1,641,049,179.218Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Xi'an Novastar Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
ElvalHalcor S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ningbo Yunsheng (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xi'an Sinofuse Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Fleury S.A.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Wintech-Nano Suzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sunrise Energy Metals Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Azad Engineering Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shenzhen Xinyichang Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen KTC Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shandong Longda Meishi Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.